product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Estrogen Receptor α (D8H8) Rabbit mAb
catalog :
8644
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
D8H8
reactivity :
human, rat
application :
western blot, immunoprecipitation, chromatin immunoprecipitation
citations: 16
Published Application/Species/Sample/DilutionReference
  • chromatin immunoprecipitation; human; 1:200; loading ...; fig 3b
  • western blot; human; loading ...
Tsoi H, Man E, Chau K, Khoo U. Targeting the IL-6/STAT3 Signalling Cascade to Reverse Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer. Cancers (Basel). 2021;13: pubmed publisher
  • western blot; human; loading ...; fig 3a
Xia X, Huang C, Liao Y, Liu Y, He J, Shao Z, et al. The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression. Cell Death Dis. 2021;12:329 pubmed publisher
  • western blot; human; 1:1000; loading ...; fig 1a, 2c, 3e, 7g
Chen X, Wang K, Guo W, Li L, Yu P, Sun X, et al. UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer. Theranostics. 2020;10:1833-1848 pubmed publisher
  • western blot; human; loading ...; fig 1a
Jiang S, Zhang M, Zhang Y, Zhou W, Zhu T, Ruan Q, et al. WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling. Cell Commun Signal. 2019;17:109 pubmed publisher
  • western blot; human; loading ...; fig s2
Greer Y, Gilbert S, Gril B, Narwal R, Peacock Brooks D, Tice D, et al. MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer. Breast Cancer Res. 2019;21:27 pubmed publisher
  • western blot; human; loading ...; fig 4a
Sánchez Morgan N, Kirsch K, Trackman P, Sonenshein G. UXT Is a LOX-PP Interacting Protein That Modulates Estrogen Receptor Alpha Activity in Breast Cancer Cells. J Cell Biochem. 2017;118:2347-2356 pubmed publisher
  • immunoprecipitation; human; loading ...; fig ED8g
  • western blot; human; 1:500; loading ...; fig 2c, 4b, 4e,ED4b
Britschgi A, Duss S, Kim S, Couto J, Brinkhaus H, Koren S, et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. Nature. 2017;541:541-545 pubmed publisher
  • western blot; human; 1:1000; loading ...; fig 4C
Yu H, Jiang Y, Liu L, Shan W, Chu X, Yang Z, et al. Integrative genomic and transcriptomic analysis for pinpointing recurrent alterations of plant homeodomain genes and their clinical significance in breast cancer. Oncotarget. 2017;8:13099-13115 pubmed publisher
  • western blot; human; loading ...; fig 2g
Kang M, Jeong K, Kim W, Lee H, Gong G, Suh N, et al. Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer. Oncogene. 2017;36:1745-1752 pubmed publisher
  • western blot; human; 1:1000; tbl s6
Mair B, Konopka T, Kerzendorfer C, Sleiman K, Salic S, Serra V, et al. Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug Sensitivity. PLoS Genet. 2016;12:e1006279 pubmed publisher
  • western blot; rat; 1:500; fig s2
Radhika N, Govindaraj V, Sarangi S, Rao A. Neonatal exposure to 17β-estradiol down-regulates the expression of synaptogenesis related genes in selected brain regions of adult female rats. Life Sci. 2015;141:1-7 pubmed publisher
  • western blot; human; fig 1
Zhang Y, Wei X, Liang Y, Chen W, Zhang F, Bai J, et al. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation. PLoS ONE. 2015;10:e0135851 pubmed publisher
  • western blot; human
Ohoka N, Nagai K, Hattori T, Okuhira K, Shibata N, Cho N, et al. Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway. Cell Death Dis. 2014;5:e1513 pubmed publisher
  • western blot; human
Li L, Wang Q, Lv X, Sha L, Qin H, Wang L, et al. Expression and localization of estrogen receptor in human breast cancer and its clinical significance. Cell Biochem Biophys. 2015;71:63-8 pubmed publisher
Antognelli C, Palumbo I, Aristei C, Talesa V. Glyoxalase I inhibition induces apoptosis in irradiated MCF-7 cells via a novel mechanism involving Hsp27, p53 and NF-?B. Br J Cancer. 2014;111:395-406 pubmed publisher
Pedroni S, Turban S, Kipari T, Dunbar D, McInnes K, Saunders P, et al. Pregnancy in obese mice protects selectively against visceral adiposity and is associated with increased adipocyte estrogen signalling. PLoS ONE. 2014;9:e94680 pubmed publisher
product information
SKU :
8644S
Product-Name :
Estrogen Receptor α (D8H8) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H
Applications :
Chromatin Immunoprecipitation
Product-Category :
Nuclear Receptor Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
66
Host :
Rabbit
Target :
ER-alpha
Primary-Protein :
ER-alpha
Alt-Names :
DKFZp686N23123,ER,ER-alpha,ESR,ESR1,ESRA,Era,Estradiol receptor,Estrogen receptor,NR3A1,Nuclear receptor subfamily 3 group A member 1,estrogen receptor 1,estrogen receptor alpha delta 3*,4,5,6,7*/819-2 isoform,estrogen receptor alpha delta 4 +49 isoform,estrogen receptor alpha delta 4*,5,6,7*/654 isoform
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.